Evidence map›Paper›PMID 25653520›Full record

ArticleInternational journal of nanomedicine2015

Bio-functionalized dense-silica nanoparticles for MR/NIRF imaging of CD146 in gastric cancer.

Pu Wang, Yazhuo Qu, Chuan Li, Li Yin, Caifei Shen, Wei Chen, Shiming Yang, Xiuwu Bian, Dianchun Fang

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Magnetic Nanoparticles Mediated Thrombolysis-A Review.IEEE open journal of nanotechnology · 2023
    Article
  5. Review
  6. Review
  7. Review
  8. Imaging techniques in nanomedical research.European journal of histochemistry : EJH · 2020
    Article
  9. Image-guided tumor surgery: The emerging role of nanotechnology.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2020
    Review
  10. Nanoparticles in Gastrooncology.Visceral medicine · 2020
    Review
  11. Radiolabelled Aptamers for Theranostic Treatment of Cancer.Pharmaceuticals (Basel, Switzerland) · 2018
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Pu WangInstitute of Gastroenterology, The Third Military Medical University, Chongqing, People's Republic of China.
Yazhuo QuInstitute of Pathology, The Third Military Medical University, Chongqing, People's Republic of China.
Chuan LiDepartment of Radiology, Southwest Hospital, The Third Military Medical University, Chongqing, People's Republic of China.
Li YinInstitute of Pathology, The Third Military Medical University, Chongqing, People's Republic of China.
Caifei ShenInstitute of Gastroenterology, The Third Military Medical University, Chongqing, People's Republic of China.
Wei ChenDepartment of Radiology, Southwest Hospital, The Third Military Medical University, Chongqing, People's Republic of China.
Shiming YangDepartment of Gastroenterology, Xinqiao Hospital, The Third Military Medical University, Chongqing, People's Republic of China.
Xiuwu BianInstitute of Pathology, The Third Military Medical University, Chongqing, People's Republic of China.
Dianchun FangInstitute of Gastroenterology, The Third Military Medical University, Chongqing, People's Republic of China.
Army Medical University · CNSouthwest Hospital · CNXinqiao Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeNano dense-silica (dSiO2) has many advantages such as adjustable core-shell structure, multiple drug delivery, and controllable release behavior. Improving the gastric tumor-specific targeting efficiency based on the development of various strategies is crucial for anti-cancer drug delivery systems.

methodsSuperparamagnetic iron oxide nanoparticles (SPION) were coated with dSiO2 as core-shell nanoparticles, and labeled with near infra-red fluorescence (NIRF) dye 800ZW (excitation wavelength: 778 nm/emission wavelength: 806 nm) and anti-CD146 monoclonal antibody YY146 for magnetic resonance (MR)/NIRF imaging study in xenograft gastric cancer model. The morphology and the size of pre- and postlabeling SPION@dSiO2 core-shell nanoparticles were characterized using transmission electron microscopy. Iron content in SPION@dSiO2 nanoparticles was measured by inductively coupled plasma optical emission spectrometry. Fluorescence microscopy and fluorescence-activated cell sorter studies were carried out to confirm the binding specificity of YY146 and 800ZW-SPION@dSiO2-YY146 on MKN45 cells. In vivo and in vitro NIRF imaging, control (nanoparticles only) and blocking studies, and histology were executed on MKN45 tumor-bearing nude mice to estimate the affinity of 800ZW-SPION@dSiO2-YY146 to target tumor CD146.

results800ZW-SPION@dSiO2-YY146 nanoparticles were uniformly spherical in shape and dispersed evenly in a cell culture medium. The diameter of the nanoparticle was 20-30 nm with 15 nm SPION core and ~10 nm SiO2 shell, and the final concentration was 1.7 nmol/mL. Transverse relaxivity of SPION@dSiO2 dispersed in water was measured to be 110.57 mM(-1)·s(-1). Fluorescence activated cell sorter analysis of the nanoparticles in MKN45 cells showed 14-fold binding of 800ZW-SPION@dSiO2-YY146 more than the control group 800ZW-SPION@dSiO2. Series of NIRF imaging post intravenous injection of 800ZW-SPION@dSiO2-YY146 demonstrated that the MKN45 xenograft tumor model could be clearly identified as early as a time point of 30 minutes postinjection. Quantitative analysis revealed that the tumor uptake peaked at 24 hours postinjection.

conclusionThis is the first successful study of functional nanoparticles for MR/NIRF imaging of cell surface glycoprotein CD146 in gastric cancer model. Our results suggest that 800ZW-SPION@dSiO2-YY146 nanoparticles will be applicable in tumor for image-guided therapy/surgery.

Indexed as

Drug Delivery SystemsAnimalsAntibodies, MonoclonalCD146 AntigenCell Line, TumorFemaleFluorescent Antibody TechniqueHumansMagnetic Resonance ImagingMiceMice, NudeMicroscopy, ConfocalMicroscopy, FluorescenceNanoparticlesSilicon DioxideSpectrometry, FluorescenceAntibodies, MonoclonalCD146 AntigenSilicon DioxideEMTgastric cancernanotechnologySPIONSPION@dSiO2xenograft

Identifiers

PMID25653520
PMCPMC4309778
OpenAlexW1992150103

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.